Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-30, Stock:LLY, The news for the past five days is as follows:
2019-10-23: NEWS1: Two Drugmakers Beat Earnings Forecasts — So Why Did One Topple?.NEWS2: Boeing, Caterpillar report disappointing earnings, but their shares bounce back.NEWS3: Two Drugmakers Beat Earnings Forecasts — So Why Did One Topple?.NEWS4: Eli Lilly to target cancer drug developers for deals.NEWS5: Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down.NEWS6: Eli Lilly Earned More Than Expected. Here’s Why the Stock Is Falling Anyway..NEWS7: Eli Lilly (LLY) Surpasses Q3 Earnings Estimates.NEWS8: Eli Lilly Reports Mixed Q3 Earnings, Raises Guidance.NEWS9: Eli Lilly, Alexion Earnings Top Q3 Views, But Stocks Diverge.NEWS10: Eli Lilly raises earnings guidance as new drugs boost sales.NEWS11: Eli Lilly tops profit estimates in latest quarter as revenue falls short.NEWS12: UPDATE 4-Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop.NEWS13: Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop.NEWS14: Eli Lilly reports 9% rise in third-quarter profit.NEWS15: Eli Lilly misses sales estimates as top-seller Trulicity disappoints.NEWS16: Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance.NEWS17: Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno.NEWS18: Eli Lilly Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance.NEWS19: Stocks - Caterpillar, Eli Lilly, Texas Instruments Fall Premarket; Boeing Rises.
2019-10-24: NEWS1: Edited Transcript of LLY earnings conference call or presentation 23-Oct-19 1:00pm GMT.NEWS2: Eli Lilly and Company Reaffirms Buy (LLY).NEWS3: Lilly Announces Cash Tender Offer for Up to $2.0 Billion Aggregate Principal Amount of Its Outstanding Debt Securities.NEWS4: The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise.
2019-10-25: NEWS1: Pharma Stock Roundup: LLY, NVS, AZN's Q3 Earnings, Updates From FDA.
2019-10-28: NEWS1: China could quickly become the world’s largest antidepressant market, but hurdles remain.NEWS2: Weekly CEO Buys Highlight.NEWS3: Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More.NEWS4: 5 Dividend Stocks to Buy Even Though Investing Pros Are Really Gloomy.NEWS5: 5 Dividend Stocks to Weather an Ugly Year-End.
2019-10-29: NEWS1: Analysts Like Biogen's Chances of Getting Alzheimer's Drug Approved.NEWS2: 6 Stocks With Low Price-Sales Ratios.NEWS3: Incyte (INCY) Beats on Q3 Earnings & Sales, Ups Jakafi View.NEWS4: S&P Goes Where It’s Never Gone Before.NEWS5: Eli Lilly and Company -- Moody's assigns A2 rating to Eli Lilly's euro notes; stable outlook.NEWS6: 5 Lagging Blue Chips That Can Lead as Investors Turn Bearish.

Answer: Rise